Pages that link to "Q48880005"
Jump to navigation
Jump to search
The following pages link to Treatment of a major depression episode suppresses markers of bone turnover in premenopausal women (Q48880005):
Displaying 11 items.
- Depression, antidepressants, and bone health in older adults: a systematic review (Q27010527) (← links)
- Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption (Q33789841) (← links)
- Effects of escitalopram on markers of bone turnover: a randomized clinical trial (Q34130880) (← links)
- Serotonin and the bone assessment (Q35339741) (← links)
- Will posttranslational modifications of brain proteins provide novel serological markers for dementias? (Q36072517) (← links)
- Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose (Q36855935) (← links)
- The complex interplay of depression and falls in older adults: a clinical review. (Q36936093) (← links)
- The serotonin and the bone assessment (Q37050668) (← links)
- Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect. (Q37317822) (← links)
- Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS). (Q37392391) (← links)
- The Impact of Psychotropic Medications on Bone Health in Youth (Q57151377) (← links)